NCT06830733
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06830733
Title Study to Evaluate the Safety and Efficacy of ARI0002h, for the Initial Treatment of Patients With Primary Plasma Cell Leukaemia (GEM-PLASMACAR)
Acronym GEM-PLASMACAR
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Fundacion Clinic per a la Recerca Biomédica
Indications
Therapies
Age Groups: adult | senior
Covered Countries ESP


No variant requirements are available.